The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Celecoxib Krka 100mg capsules, hard

KRKA, d.d., Novo mestoPA1347/033/001

Main Information

Trade NameCelecoxib Krka 100mg capsules, hard
Active SubstancesCelecoxib
Dosage FormCapsule, hard
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/033/001

Group Information

ATC CodeM01AH Coxibs
M01AH01 celecoxib


License statusAuthorised
Licence Issued29/11/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back